Carnitine derivatives in hereditary cardiomyopathic animals

Area of Science:

• Biochemistry
• Cardiology
• Animal Models

Background:

• Hereditary cardiomyopathy is a spontaneous condition observed in BIO 14.6 Syrian hamsters and diabetic KK mice.
• Carnitine metabolism plays a crucial role in cardiac energy production and function.

Purpose of the Study:

• To investigate the pathophysiological role of carnitine metabolism in hereditary cardiomyopathy.
• To compare carnitine derivative levels and cardiac histology in affected hamsters and mice models.

Main Methods:

• Analysis of tissue carnitine derivatives (free, short-chain acylcarnitine, total carnitine) in heart, liver, and skeletal muscles.
• Histological examination of cardiac tissues to assess degeneration and necrosis patterns.

Main Results:

• BIO 14.6 hamsters exhibited significantly lower free, short-chain acylcarnitine, and total carnitine levels in heart tissue compared to controls.
• No significant differences in carnitine derivatives were observed in the liver or skeletal muscles of BIO 14.6 hamsters.
• KK mice showed no significant changes in carnitine derivatives across tissues, despite developing cardiomyopathy.
• Histology revealed heart muscle degeneration and necrosis in both models, with distinct patterns: myocytolytic necrosis in hamsters and right ventricular predilection in mice.

Conclusions:

• Carnitine deficiency in the heart may contribute to hereditary cardiomyopathy in BIO 14.6 hamsters.
• KK mice represent a distinct model of hereditary cardiomyopathy with different metabolic and pathological features.
• Further research into carnitine's role is warranted for understanding and treating hereditary cardiomyopathies.